Showing results (41-50 of 79) with videos related to
Sort By:
Pageof 8
Nature Communications|November 8, 2022
Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cellsYang Sun, Lu Hu, Zhipeng Tao, et al.Journal of Medicinal Chemistry|January 15, 2020
Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop CysteineGuangyan Du, Suman Rao, Deepak Gurbani, et al.Proceedings of the National Academy of Sciences of the United States of America|October 14, 2025
Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7)Isabella Jaen Maisonet, Mona Sharafi, Emilie J Korchak, et al.Biorxiv : the Preprint Server for Biology|January 23, 2024
A comprehensive landscape of the zinc-regulated human proteomeNils Burger, Melanie J Mittenbühler, Haopeng Xiao, et al.Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|April 28, 2016
In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic modelShannon F Rudy, J Chad Brenner, Jennifer L Harris, et al.Bioorganic & Medicinal Chemistry Letters|September 17, 2008
Discovery of pyrimidine benzimidazoles as Lck inhibitors: part IGuobao Zhang, Pingda Ren, Nathanael S Gray, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor ModulatorShifeng Pan, Nathanael S Gray, Wenqi Gao, et al.Nature Chemical Biology|March 23, 2021
Discovery and resistance mechanism of a selective CDK12 degraderBaishan Jiang, Yang Gao, Jianwei Che, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part IIGuobao Zhang, Pingda Ren, Nathanael S Gray, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 15, 2024
Discovery of Potent Degraders of the Dengue Virus Envelope ProteinZhengnian Li, Han-Yuan Liu, Zhixiang He, et al.Pageof 8